Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Verrica Pharmaceuticals Inc VRCA

Healthcare
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. We are also developing YCANTH for potential... see more

Recent & Breaking News (NDAQ:VRCA)

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

GlobeNewswire July 14, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA

GlobeNewswire July 9, 2020

The Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire July 9, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire July 8, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire July 7, 2020

Shareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Shareholders

Business Wire July 6, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA

ACCESSWIRE IA July 6, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA

Canada NewsWire July 1, 2020

VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

ACCESSWIRE IA July 1, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire June 30, 2020

The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Verrica Pharmaceuticals Inc. Investors (VRCA)

Business Wire June 30, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire June 30, 2020

Verrica Pharmaceuticals Provides Regulatory Update on VP-102

GlobeNewswire June 29, 2020

Verrica Pharmaceuticals Announces Positive Results from Two New Pooled Analyses of the Phase 3 CAMP Trials of VP-102 in Molluscum Contagiosum

GlobeNewswire June 12, 2020

Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors

GlobeNewswire June 10, 2020

Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference

GlobeNewswire May 27, 2020

Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results

GlobeNewswire May 7, 2020

Verrica Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 6, 2020

Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 9, 2020

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

GlobeNewswire March 13, 2020